Glycosaminoglycan entrapment by fibrin in engineered heart valve tissues
Authors:
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 9 (9) , 8149-8157
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrixCardiovascular Pathology, 2012
- Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valveActa Biomaterialia, 2008
- Prenatally Fabricated Autologous Human Living Heart Valves Based on Amniotic Fluid–Derived Progenitor Cells as Single Cell SourceCirculation, 2007
- Living Autologous Heart Valves Engineered From Human Prenatally Harvested ProgenitorsCirculation, 2006
- Umbilical cord cells as a source of cardiovascular tissue engineeringStem Cell Reviews, 2006
- Stability and function of glycosaminoglycans in porcine bioprosthetic heart valvesBiomaterials, 2006
- From Stem Cells to Viable Autologous Semilunar Heart ValveCirculation, 2005
- Ultrastructure of Proteoglycans in Tissue-Engineered Cardiovascular StructuresTissue Engineering, 2002
- Functional Living Trileaflet Heart Valves Grown In VitroCirculation, 2000
- Aortic valve cusp microstructure: The role of elastinThe Annals of Thoracic Surgery, 1995